JournalsHub
.online
Find My Journal
KM

Kabir Mody

Independent Researcher

ORCID 0000-0003-3254-2990
166
Publications
5,793
Citations
32
H-Index
74
i10-Index
27.08
2yr Mean Cite
-
Cite/Paper
Data combined from OpenAlex . OA = OpenAlex S2 = Semantic Scholar
Verify on Google Scholar

Publication & Citation Trends

Most Cited Works

Tremelimumab plus Durvalumab in Unresectable Hepatocellular Carcinoma OA
Ghassan K. Abou‐Alfa, George Lau, Masatoshi Kudo, Stephen L. Chan, Robin Kate Kelley +26 more
NEJM Evidence 2022
1,338
Pharmacologic resistance in colorectal cancer: a review OA
William A. Hammond, Abhisek Swaika, Kabir Mody
Therapeutic Advances in Medical Oncology 2015
517
Phase 3 randomized, open-label, multicenter study of tremelimumab (T) and durvalumab (D) as first-line therapy in patients (pts) with unresectable hepatocellular carcinoma (uHCC): HIMALAYA.
Ghassan K. Abou‐Alfa, Stephen L. Chan, Masatoshi Kudo, George Lau, Robin Kate Kelley +15 more
Journal of Clinical Oncology 2022
394
Validation of Microsatellite Instability Detection Using a Comprehensive Plasma-Based Genotyping Panel
Jason Willis, Martina I. Lefterova, Alexander Artyomenko, Pashtoon Murtaza Kasi, Yoshiaki Nakamura +27 more
Clinical Cancer Research 2019
233
Aberrant lipid metabolism as a therapeutic target in liver cancer OA
Evans D. Pope, ErinMarie O. Kimbrough, Lalitha Padmanabha Vemireddy, Phani Keerthi Surapaneni, John A. Copland +1 more
Expert Opinion on Therapeutic Targets 2019
194

Publications

165 total

Tremelimumab plus Durvalumab in Unresectable Hepatocellular Carcinoma PDF

Ghassan K. Abou‐Alfa, George Lau, Masatoshi Kudo, Stephen L. Chan, Robin Kate Kelley et al. - NEJM Evidence, 2022
Cited by 1,338 OpenAlex

Phase 3 randomized, open-label, multicenter study of tremelimumab (T) and durvalumab (D) as first-line therapy in patients (pts) with unresectable hepatocellular carcinoma (uHCC): HIMALAYA.

Ghassan K. Abou‐Alfa, Stephen L. Chan, Masatoshi Kudo, George Lau, Robin Kate Kelley et al. - Journal of Clinical Oncology, 2022
Cited by 394 OpenAlex

The clinical landscape of cell-free DNA alterations in 1671 patients with advanced biliary tract cancer PDF

J.E. Berchuck, Francesco Facchinetti, Daniel DiToro, Islam Baiev, Umair Majeed et al. - Annals of Oncology, 2022
Cited by 130 OpenAlex

Systemic Therapy and Sequencing Options in Advanced Hepatocellular Carcinoma PDF

Mohamad Bassam Sonbol, Irbaz Bin Riaz, Syed Arsalan Ahmed Naqvi, Daniel Almquist, Syeda A. Mina et al. - JAMA Oncology, 2020
Cited by 193 OpenAlex

Gemcitabine/nab-paclitaxel with pamrevlumab: a novel drug combination and trial design for the treatment of locally advanced pancreatic cancer PDF

Vincent J. Picozzi, Adnan Alseidi, Jordan Winter, Michael J. Pishvaian, Kabir Mody et al. - ESMO Open, 2020
Cited by 71 OpenAlex

Validation of Microsatellite Instability Detection Using a Comprehensive Plasma-Based Genotyping Panel

Jason Willis, Martina I. Lefterova, Alexander Artyomenko, Pashtoon Murtaza Kasi, Yoshiaki Nakamura et al. - Clinical Cancer Research, 2019
Cited by 233 OpenAlex

Aberrant lipid metabolism as a therapeutic target in liver cancer PDF

Evans D. Pope, ErinMarie O. Kimbrough, Lalitha Padmanabha Vemireddy, Phani Keerthi Surapaneni, John A. Copland et al. - Expert Opinion on Therapeutic Targets, 2019
Cited by 194 OpenAlex

The Role of Maintenance Strategies in Metastatic Colorectal Cancer PDF

Mohamad Bassam Sonbol, Luke Mountjoy, Belal Firwana, Alex J. Liu, Diana Almader‐Douglas et al. - JAMA Oncology, 2019
Cited by 108 OpenAlex

Circulating Tumor DNA Profiling of Advanced Biliary Tract Cancers

Kabir Mody, Pashtoon Murtaza Kasi, Ju-Dong Yang, Phani Keerthi Surapaneni, Tanios Bekaii‐Saab et al. - JCO Precision Oncology, 2019
Cited by 81 OpenAlex

Antiangiogenic Therapy in Colorectal Cancer

Kabir Mody, Candice Baldeo, Tanios Bekaii‐Saab - The Cancer Journal, 2018
Cited by 102 OpenAlex

Research Topics

Pancreatic and Hepatic Oncology Research (54) Cholangiocarcinoma and Gallbladder Cancer Studies (54) Cancer Genomics and Diagnostics (43) Hepatocellular Carcinoma Treatment and Prognosis (30) Colorectal Cancer Treatments and Studies (22)

Frequent Co-Authors

TA
Tanios Bekaii‐Saab
5 joint publications
MI
Mitesh J. Borad
4 joint publications
RO
Robin Kate Kelley
3 joint publications
MO
Mohamad Bassam Sonbol
3 joint publications
DA
Daniel H. Ahn
3 joint publications
GH
Ghassan K. Abou‐Alfa
2 joint publications

Affiliations

Dartmouth College
US 2015 - 2015
Norwalk Hospital
US 2010 - 2010
Dartmouth–Hitchcock Medical Center
US 2014 - 2013
Mayo Clinic
US 2021 - 2021
The University of Texas MD Anderson Cancer Center
US 2019 - 2019

External Profiles

OpenAlex Profile Search Semantic Scholar ORCID Profile Google Scholar

Share Profile

Back to Researchers
Comparison Shortlist
0 journals
Est. APC Budget: $0
Compare Now